Results 201 to 210 of about 68,681 (256)
Some of the next articles are maybe not open access.

Antihypertensive agents

Journal of PeriAnesthesia Nursing, 1999
Fifty million Americans suffer from hypertension. During the perioperative period, hypertension is a frequent finding owing to a variety of mechanisms including anxiety, pain, and preexisting conditions. This article explores the pharmaceutical agents commonly used in the treatment of hypertension. Particular attention is directed to drugs administered
openaire   +2 more sources

Antihypertensive Agents

Therapeutic Drug Monitoring, 1981
Hypertension is a disease more common to advanced societies, possibly due to diet and life style. It is a disease that can be readily controlled, and active efforts to decrease blood pressure correlate with decreased incidence of cardiovascular disease.
T P, Moyer, S G, Sheps
openaire   +2 more sources

Antihypertensive Agents 1962–1968

1969
Seven years ago Schlittler, Druey, and Marxer [207] reported on antihypertensive agents in a previous volume of this series. Since this review appeared, research in the field of antihypertensive drugs has made steady progress. Although spectacular breakthroughs — exemplified by such pioneering feats as the discoveries of reserpine, hydralazine ...
O, Schier, A, Marxer
openaire   +2 more sources

Chapter 6 Antihypertensive Agents

1990
Publisher Summary Cardiovascular disease accounts for more expenditures on health care than any other diagnostic category and hypertension is the most prevalent cardiovascular condition. While unit costs for hypertension treatment are low, aggregate costs are enormous because of the large and growing population of patients who are treated ...
Edward W. Petriilo   +2 more
openaire   +1 more source

Centrally Acting Antihypertensive Agents

Journal of Cardiovascular Pharmacology, 1988
In spite of the fact that plasma catecholamine levels, baroreflex activity, and hemodynamic pattern significantly change with age and drugs whose action is mediated via the sympathetic nervous system might be expected to cause different effects, the limited available data suggest that both alpha-methyldopa and clonidine lower blood pressure to a ...
openaire   +2 more sources

Antihypertensive Agents

New England Journal of Medicine, 1962
E, SCHLITTLER, J, DRUEY, A, MARXER
openaire   +4 more sources

Nephroprotection by Antihypertensive Agents

Journal of Cardiovascular Pharmacology, 1994
Arterial hypertension is one of the few factors confirmed to accelerate the development of renal failure. Conversely, several studies have documented that systematic reduction of the blood pressure slows the progression of renal failure. It is postulated that 24-h reduction of the blood pressure should be achieved, best controlled by ambulatory blood ...
openaire   +2 more sources

New Antihypertensive Agents: Benefit of Treatment

Journal of Cardiovascular Pharmacology, 1992
Large-scale end-point trials have demonstrated that antihypertensive treatment reverses the risk of stroke attributable to high blood pressure and probably reduces the incidence of myocardial infarction. Despite this major achievement in therapeutics, substantial goals still need to be achieved.
openaire   +2 more sources

Newer antihypertensive agents

Postgraduate Medicine, 1983
Captopril (Capoten) and minoxidil (Loniten) have recently become generally available for treatment of hypertension, and calcium channel blockers, although not yet officially approved for this indication, clearly have potential as antihypertensive agents. Captopril, the only available inhibitor of angiotensin-converting enzyme, is particularly effective
openaire   +3 more sources

Antihypertensive Agents

International Anesthesiology Clinics, 1968
openaire   +3 more sources

Home - About - Disclaimer - Privacy